Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
Biogen teams up with gene-editing startup Scribe on ALS program
Pharmaforum
Thu, 10/8/20 - 11:09 am
Scribe Therapeutics
Biogen
ALS
CRISPR
Nobel Prize in chemistry goes to CRISPR pioneers Doudna, Charpentier
Fierce Biotech
Wed, 10/7/20 - 11:06 am
Nobel Prize
chemistry
Jennifer Doudna
Emmanuelle Charpentier
CRISPR
CRISPR Technology Edges Closer to Commercial Use
BioSpace
Thu, 10/1/20 - 11:13 pm
CRISPR
C. difficile
Agios helps identify genes that allow cancer to escape the immune system
Fierce Biotech
Thu, 09/24/20 - 10:18 am
CRISPR
cancer
Agios Pharmaceuticals
immuno-oncology
Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein
Forbes
Thu, 08/13/20 - 09:57 am
Mammoth Biosciences
gene editing
CRISPR
University of California Berkeley
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Fri, 08/7/20 - 10:52 am
Editas Medicine
Allergan
AbbVie
gene editing
CRISPR
Bayer helps Harvard spinout Vesigen to $28.5M series A
Fierce Biotech
Wed, 07/22/20 - 10:39 am
Bayer
Vesigen Therapeutics
Harvard
RNAi
MRNA
CRISPR
A Jennifer Doudna-led team finds a new CRISPR enzyme in the giant viruses of a California mud bog
Endpoints
Fri, 07/17/20 - 11:11 am
Jennifer Doudna
CRISPR
viruses
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Stat
Sun, 06/28/20 - 07:10 pm
CRISPR
Verve Therapeutics
stem cells
cholesterol
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
BioPharma Dive
Fri, 06/12/20 - 11:11 am
CRISPR
gene therapy
beta thalassemia
sickle cell disease
CRISPR Therapeutics
Vertex
Bluebird Bio
EHA
Stanford team deploys CRISPR gene editing to fight COVID-19
Fierce Biotech
Fri, 06/5/20 - 10:35 am
Stanford University
CRISPR
gene editing
pandemic
COVID-19
Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Mon, 06/1/20 - 10:30 am
Regeneron
Intellia Therapeutics
hemophilia A
hemophilia B
CRISPR
drug development
Biotech R&D Software Startup Benchling, Started By MIT Undergrads, Scores $850 Million Valuation Amid Coronavirus Pandemic
Forbes
Thu, 05/28/20 - 10:34 am
R&D
CRISPR
MIT
COVID-19
Benchling
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
Motley Fool
Fri, 05/22/20 - 10:30 am
gene editing
CRISPR
Editas Medicine
Intellia
earnings
Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic
MedCity News
Wed, 05/20/20 - 12:20 pm
Mammoth Biosciences
GSK
CRISPR
diagnostics
COVID-19
Jennifer Doudna
How CRISPR can help us win the fight against the pandemic
MedCity News
Tue, 05/12/20 - 10:10 pm
CRISPR
gene editing
pandemic
COVID-19
R&D
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus Test
Forbes
Thu, 05/7/20 - 10:29 pm
FDA
CRISPR
COVID-19
diagnostics
Sherlock Biosciences
New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say
Stat
Tue, 05/5/20 - 01:00 pm
CRISPR
diagnostics
COVID-19
pandemic
MIT
Broad Institute
Reversing diabetes with CRISPR and patient-derived stem cells
Fierce Biotech
Wed, 04/22/20 - 10:31 pm
diabetes
CRISPR
stem cells
Scientists tap CRISPR’s search-and-detect skills to create a rapid Covid-19 test
Stat
Sat, 04/18/20 - 11:27 pm
COVID-19
diagnostics
CRISPR
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »